6-32058330-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001365276.2(TNXB):​c.7553G>A​(p.Gly2518Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.711 in 1,611,184 control chromosomes in the GnomAD database, including 409,280 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G2518G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.69 ( 36743 hom., cov: 31)
Exomes 𝑓: 0.71 ( 372537 hom. )

Consequence

TNXB
NM_001365276.2 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.350

Publications

45 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.462437E-7).
BP6
Variant 6-32058330-C-T is Benign according to our data. Variant chr6-32058330-C-T is described in ClinVar as Benign. ClinVar VariationId is 261162.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.75 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNXBNM_001365276.2 linkc.7553G>A p.Gly2518Glu missense_variant Exon 22 of 44 ENST00000644971.2 NP_001352205.1
TNXBNM_001428335.1 linkc.8294G>A p.Gly2765Glu missense_variant Exon 23 of 45 NP_001415264.1
TNXBNM_019105.8 linkc.7553G>A p.Gly2518Glu missense_variant Exon 22 of 44 NP_061978.6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNXBENST00000644971.2 linkc.7553G>A p.Gly2518Glu missense_variant Exon 22 of 44 NM_001365276.2 ENSP00000496448.1
TNXBENST00000647633.1 linkc.8294G>A p.Gly2765Glu missense_variant Exon 23 of 45 ENSP00000497649.1
TNXBENST00000375244.7 linkc.7553G>A p.Gly2518Glu missense_variant Exon 22 of 44 5 ENSP00000364393.3

Frequencies

GnomAD3 genomes
AF:
0.692
AC:
104635
AN:
151308
Hom.:
36712
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.635
Gnomad AMI
AF:
0.737
Gnomad AMR
AF:
0.761
Gnomad ASJ
AF:
0.852
Gnomad EAS
AF:
0.634
Gnomad SAS
AF:
0.748
Gnomad FIN
AF:
0.651
Gnomad MID
AF:
0.788
Gnomad NFE
AF:
0.707
Gnomad OTH
AF:
0.722
GnomAD2 exomes
AF:
0.720
AC:
173470
AN:
240990
AF XY:
0.724
show subpopulations
Gnomad AFR exome
AF:
0.639
Gnomad AMR exome
AF:
0.783
Gnomad ASJ exome
AF:
0.848
Gnomad EAS exome
AF:
0.617
Gnomad FIN exome
AF:
0.651
Gnomad NFE exome
AF:
0.711
Gnomad OTH exome
AF:
0.724
GnomAD4 exome
AF:
0.713
AC:
1040295
AN:
1459760
Hom.:
372537
Cov.:
65
AF XY:
0.716
AC XY:
519633
AN XY:
726150
show subpopulations
African (AFR)
AF:
0.647
AC:
21615
AN:
33410
American (AMR)
AF:
0.783
AC:
34953
AN:
44662
Ashkenazi Jewish (ASJ)
AF:
0.845
AC:
22063
AN:
26124
East Asian (EAS)
AF:
0.655
AC:
25994
AN:
39690
South Asian (SAS)
AF:
0.775
AC:
66874
AN:
86244
European-Finnish (FIN)
AF:
0.648
AC:
33653
AN:
51958
Middle Eastern (MID)
AF:
0.772
AC:
4447
AN:
5764
European-Non Finnish (NFE)
AF:
0.709
AC:
787688
AN:
1111586
Other (OTH)
AF:
0.713
AC:
43008
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
17460
34919
52379
69838
87298
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19810
39620
59430
79240
99050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.692
AC:
104717
AN:
151424
Hom.:
36743
Cov.:
31
AF XY:
0.691
AC XY:
51152
AN XY:
74010
show subpopulations
African (AFR)
AF:
0.635
AC:
25977
AN:
40892
American (AMR)
AF:
0.761
AC:
11627
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.852
AC:
2958
AN:
3470
East Asian (EAS)
AF:
0.635
AC:
3275
AN:
5156
South Asian (SAS)
AF:
0.746
AC:
3589
AN:
4812
European-Finnish (FIN)
AF:
0.651
AC:
6871
AN:
10562
Middle Eastern (MID)
AF:
0.776
AC:
228
AN:
294
European-Non Finnish (NFE)
AF:
0.707
AC:
48012
AN:
67952
Other (OTH)
AF:
0.719
AC:
1509
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1570
3141
4711
6282
7852
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
820
1640
2460
3280
4100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.708
Hom.:
19963
Bravo
AF:
0.699
TwinsUK
AF:
0.714
AC:
2647
ALSPAC
AF:
0.710
AC:
2736
ESP6500AA
AF:
0.652
AC:
1507
ESP6500EA
AF:
0.701
AC:
3513
ExAC
AF:
0.714
AC:
83884
Asia WGS
AF:
0.693
AC:
2414
AN:
3478
EpiCase
AF:
0.730
EpiControl
AF:
0.732

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome due to tenascin-X deficiency Benign:2
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Vesicoureteral reflux 8 Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Sep 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Dec 04, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.047
BayesDel_addAF
Benign
-0.85
T
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.077
DANN
Benign
0.16
DEOGEN2
Benign
0.022
T;.;T;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.00094
N
LIST_S2
Benign
0.034
.;T;T;T
MetaRNN
Benign
9.5e-7
T;T;T;T
MetaSVM
Benign
-0.95
T
PhyloP100
-0.35
PrimateAI
Benign
0.33
T
PROVEAN
Benign
2.3
.;.;N;.
REVEL
Benign
0.024
Sift
Benign
1.0
.;.;T;.
Sift4G
Benign
1.0
.;.;T;T
Vest4
0.025
ClinPred
0.0011
T
GERP RS
3.3
Varity_R
0.025
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1009382; hg19: chr6-32026107; COSMIC: COSV64485077; API